The SPmAb2.1 and SPmAb-6 are the first ever antibodies produced against the signal peptide domain of the MUC1 tumor associated antigen. ​The isolation of antibodies targeting the signal peptide additional of other undisclosed targets is underway. Vaxil can isolate signal peptide (SP) epitopes that can be used as antigens for generating more specific antibodies against known and novel targets.
Click below to read more